• Title/Summary/Keyword: Obstetrics and gynecology department

Search Result 2,168, Processing Time 0.029 seconds

Isotretinoin exposure in pregnant women in Korea

  • Kim, Nae Ry;Yoon, So Ra;Choi, June Seek;Ahn, Hyun Kyong;Lee, So-Young;Hong, Dal Soo;Yun, Jeong Sup;Hong, Seong Yeon;Kim, Yoon Ha;Han, Jung Yeol
    • Obstetrics & gynecology science
    • /
    • v.61 no.6
    • /
    • pp.649-654
    • /
    • 2018

  • Objective Isotretinoin is a notorious teratogen otherwise used for the treatment of acne vulgaris. Some countries, including those in North America and the European Union, implemented the pregnancy prevention program (PPP); however, no PPP has yet been established in South Korea. So the aim of this study was to evaluate the rate of pregnant women exposed to isotretinoin among the callers of the Korean Mother Safe Counseling Center. Methods This is a prospective cohort study. We evaluated the demographic characteristics, obstetric history, and isotretinoin exposure of pregnant women based on the mother safe registry from April 2010 to July 2016. Results Among 22,374 callers, 650 (2.9%) pregnant women were exposed to isotretinoin. The mean age was $29.0{\pm}4.4$ years in the isotretinoin-exposed group and $32.0{\pm}4.2$ years in the unexposed group (P<0.001). Moreover, the incidence of pregnancies within 30 days after isotretinoin discontinuation or during isotretinoin intake was 78.9% (513/650). The median duration of isotretinoin exposure was 18 (1-4,231) days. Furthermore, from 2011 to 2015, the incidence of isotretinoin exposure was $2.9{\pm}1.2$ pregnancies per 10,000 births in South Korea. Conclusion Approximately 80% of pregnant women are exposed to isotretinoin within the recommended 30 days of contraception or during pregnancy. Therefore, the PPP has to be established in South Korea.

  • https://doi.org/10.5468/ogs.2018.61.6.649 인용